135 related articles for article (PubMed ID: 8269590)
1. Effect of hemoglobin solution on the response of intracranial and subcutaneous 9L tumors to antitumor alkylating agents.
Teicher BA; Holden SA; Menon K; Hopkins RE; Gawryl MS
Cancer Chemother Pharmacol; 1993; 33(1):57-62. PubMed ID: 8269590
[TBL] [Abstract][Full Text] [Related]
2. Increased efficacy of chemo- and radio-therapy by a hemoglobin solution in the 9L gliosarcoma.
Teicher BA; Dupuis NP; Emi Y; Ikebe M; Kakeji Y; Menon K
In Vivo; 1995; 9(1):11-8. PubMed ID: 7669943
[TBL] [Abstract][Full Text] [Related]
3. Oxygenation of tumors by a hemoglobin solution.
Teicher BA; Schwartz GN; Alvarez Sotomayor E; Robinson MF; Dupuis NP; Menon K
J Cancer Res Clin Oncol; 1993; 120(1-2):85-90. PubMed ID: 8270614
[TBL] [Abstract][Full Text] [Related]
4. Oxygenation of the rat 9L gliosarcoma and the rat 13672 mammary carcinoma with various doses of a hemoglobin solution.
Teicher BA; Holden SA; Dupuis NP; Kusomoto T; Liu M; Liu F; Menon K
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):827-33. PubMed ID: 7994406
[TBL] [Abstract][Full Text] [Related]
5. Influence of an anti-angiogenic treatment on 9L gliosarcoma: oxygenation and response to cytotoxic therapy.
Teicher BA; Holden SA; Ara G; Dupuis NP; Liu F; Yuan J; Ikebe M; Kakeji Y
Int J Cancer; 1995 May; 61(5):732-7. PubMed ID: 7768649
[TBL] [Abstract][Full Text] [Related]
6. Increased tumor oxygenation and radiation sensitivity in two rat tumors by a hemoglobin-based, oxygen-carrying preparation.
Robinson MF; Dupuis NP; Kusumoto T; Liu F; Menon K; Teicher BA
Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(3):431-8. PubMed ID: 7493064
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of cisplatin efficacy by thalidomide in a 9L rat gliosarcoma model.
Murphy S; Davey RA; Gu XQ; Haywood MC; McCann LA; Mather LE; Boyle FM
J Neurooncol; 2007 Nov; 85(2):181-9. PubMed ID: 17534579
[TBL] [Abstract][Full Text] [Related]
8. Systemic BCNU enhances the efficacy of local delivery of a topoisomerase I inhibitor against malignant glioma.
Storm PB; Renard VM; Moriarity JL; Tyler B; Wilentz RE; Brem H; Weingart JD
Cancer Chemother Pharmacol; 2004 Oct; 54(4):361-7. PubMed ID: 15197484
[TBL] [Abstract][Full Text] [Related]
9. Interstitial chemotherapy of experimental brain tumors: comparison of intratumoral injection versus polymeric controlled release.
Buahin KG; Brem H
J Neurooncol; 1995 Nov; 26(2):103-10. PubMed ID: 8787852
[TBL] [Abstract][Full Text] [Related]
10. Intralesionally implanted cisplatin plus systemic carmustine for the treatment of brain tumor in rats.
Kong Q; Kleinschmidt-DeMasters BK; Lillehei KO
J Surg Oncol; 1998 Oct; 69(2):76-82. PubMed ID: 9808509
[TBL] [Abstract][Full Text] [Related]
11. Increased tumor cures using combined radiosurgery and BCNU in the treatment of 9l glioma in the rat brain.
Khil MS; Kolozsvary A; Apple M; Kim JH
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):511-6. PubMed ID: 10802380
[TBL] [Abstract][Full Text] [Related]
12. Measurement of sister chromatid exchange induction in intracerebral brain tumors as a method for evaluation of therapeutic drug combinations.
Bodell WJ
Anticancer Res; 2000; 20(5A):3099-103. PubMed ID: 11062728
[TBL] [Abstract][Full Text] [Related]
13. In vivo measurement of tumor blood oxygenation by near-infrared spectroscopy: immediate effects of pentobarbital overdose or carmustine treatment.
Steen RG; Kitagishi K; Morgan K
J Neurooncol; 1994; 22(3):209-20. PubMed ID: 7760097
[TBL] [Abstract][Full Text] [Related]
14. The role of minocycline in the treatment of intracranial 9L glioma.
Weingart JD; Sipos EP; Brem H
J Neurosurg; 1995 Apr; 82(4):635-40. PubMed ID: 7897527
[TBL] [Abstract][Full Text] [Related]
15. Liposome-mediated therapy of intracranial brain tumors in a rat model.
Sharma US; Sharma A; Chau RI; Straubinger RM
Pharm Res; 1997 Aug; 14(8):992-8. PubMed ID: 9279878
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the relationship between MR estimates of blood oxygen saturation and hypoxia: effect of an antiangiogenic treatment on a gliosarcoma model.
Lemasson B; Christen T; Serduc R; Maisin C; Bouchet A; Le Duc G; Rémy C; Barbier EL
Radiology; 2012 Dec; 265(3):743-52. PubMed ID: 22996750
[TBL] [Abstract][Full Text] [Related]
17. Effect of Fluosol-DA on the response of intracranial 9L tumors to X rays and BCNU.
Teicher BA; Herman TS; Rose CM
Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1187-92. PubMed ID: 3141321
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of in vitro and in vivo antitumor activity of BCNU-loaded PLGA wafer against 9L gliosarcoma.
Lee JS; An TK; Chae GS; Jeong JK; Cho SH; Lee HB; Khang G
Eur J Pharm Biopharm; 2005 Jan; 59(1):169-75. PubMed ID: 15567315
[TBL] [Abstract][Full Text] [Related]
19. Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model.
Recinos VR; Tyler BM; Bekelis K; Sunshine SB; Vellimana A; Li KW; Brem H
Neurosurgery; 2010 Mar; 66(3):530-7; discussion 537. PubMed ID: 20173548
[TBL] [Abstract][Full Text] [Related]
20. Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: a tumor model mimicking a recurrent malignant glioma.
Saito R; Bringas J; Mirek H; Berger MS; Bankiewicz KS
J Neurosurg; 2004 Nov; 101(5):826-31. PubMed ID: 15540922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
